JP2011506497A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011506497A5 JP2011506497A5 JP2010538345A JP2010538345A JP2011506497A5 JP 2011506497 A5 JP2011506497 A5 JP 2011506497A5 JP 2010538345 A JP2010538345 A JP 2010538345A JP 2010538345 A JP2010538345 A JP 2010538345A JP 2011506497 A5 JP2011506497 A5 JP 2011506497A5
- Authority
- JP
- Japan
- Prior art keywords
- rhoc
- seq
- item
- peptide fragment
- amino acids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200701844 | 2007-12-19 | ||
| PCT/DK2008/050324 WO2009076966A2 (en) | 2007-12-19 | 2008-12-18 | Rhoc-based immunotherapy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014027157A Division JP5813801B2 (ja) | 2007-12-19 | 2014-02-17 | ＲｈｏＣに基づく免疫療法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011506497A JP2011506497A (ja) | 2011-03-03 |
| JP2011506497A5 true JP2011506497A5 (OSRAM) | 2012-01-12 |
Family
ID=59270757
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010538345A Pending JP2011506497A (ja) | 2007-12-19 | 2008-12-18 | ＲｈｏＣに基づく免疫療法 |
| JP2014027157A Active JP5813801B2 (ja) | 2007-12-19 | 2014-02-17 | ＲｈｏＣに基づく免疫療法 |
| JP2015182828A Active JP6084671B2 (ja) | 2007-12-19 | 2015-09-16 | ＲｈｏＣに基づく免疫療法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014027157A Active JP5813801B2 (ja) | 2007-12-19 | 2014-02-17 | ＲｈｏＣに基づく免疫療法 |
| JP2015182828A Active JP6084671B2 (ja) | 2007-12-19 | 2015-09-16 | ＲｈｏＣに基づく免疫療法 |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US9163077B2 (OSRAM) |
| EP (1) | EP2234635B1 (OSRAM) |
| JP (3) | JP2011506497A (OSRAM) |
| AU (1) | AU2008338063B2 (OSRAM) |
| CA (1) | CA2710061C (OSRAM) |
| DK (1) | DK2234635T3 (OSRAM) |
| ES (1) | ES2623447T3 (OSRAM) |
| PL (1) | PL2234635T3 (OSRAM) |
| WO (1) | WO2009076966A2 (OSRAM) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2234635T3 (pl) * | 2007-12-19 | 2017-08-31 | Rhovac Aps | Immunoterapia oparta na białkach rhoc |
| US10019634B2 (en) * | 2010-06-04 | 2018-07-10 | Masoud Vaziri | Method and apparatus for an eye tracking wearable computer |
| EP3294311A4 (en) * | 2015-03-05 | 2018-12-19 | Amrita Therapeutics Limited | A modified peptide as an anticancer agent |
| AU2018365800A1 (en) | 2017-11-08 | 2020-04-02 | Dana-Farber Cancer Institute, Inc. | Compositions and methods for treating cancer using RHOA dominant negative forms |
| KR101947452B1 (ko) * | 2018-04-26 | 2019-02-13 | 주식회사 에스와이테크 | 하이브리드 acp 시스템 및 그 제조방법 |
| KR200488051Y1 (ko) * | 2018-05-28 | 2018-12-07 | 주식회사 에스와이테크 | 완충 z-바 |
| WO2022017895A1 (en) | 2020-07-21 | 2022-01-27 | Rhovac Aps | Treatment of residual disease |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003040165A2 (en) * | 2000-10-19 | 2003-05-15 | Epimmune Inc. | Hla class i and ii binding peptides and their uses |
| WO1999033870A2 (en) | 1997-12-31 | 1999-07-08 | Incyte Pharmaceuticals, Inc. | Human regulatory proteins |
| US6814968B1 (en) * | 1998-06-04 | 2004-11-09 | Vanderbilt University | Inhibition of viral infection and spread with viral and RhoA-derived peptides |
| US20030039635A1 (en) * | 1998-09-30 | 2003-02-27 | Corixa Corporation | Compositions and methods for WT1 specific immunotherapy |
| WO2001041815A2 (en) * | 1999-12-10 | 2001-06-14 | Whitehead Institute For Biomedical Research | Metastasis genes and uses thereof |
| ES2330083T3 (es) * | 2000-10-27 | 2009-12-04 | Novartis Vaccines And Diagnostics S.R.L. | Acidos nucleicos y proteinas de estreptococos de los grupos a y b. |
| WO2003008537A2 (en) * | 2001-04-06 | 2003-01-30 | Mannkind Corporation | Epitope sequences |
| US7194802B2 (en) * | 2002-03-26 | 2007-03-27 | Seagate Technology Llc | Tool for certifying a head-gimbal assembly |
| DE10217035A1 (de) | 2002-04-11 | 2004-01-22 | Universitätsklinikum Charité Medizinische Fakultät der Humboldt-Universität Akademische Verwaltung - Forschung | Rekrutierungsmodule von RhoA und RhoC |
| WO2005017160A2 (en) * | 2003-08-13 | 2005-02-24 | Children's Hospital Medical Center | Mobilization of hematopoietic cells |
| US7960100B1 (en) * | 2004-04-30 | 2011-06-14 | Celera Corporation | Colon cancer targets and uses thereof |
| US7763418B2 (en) * | 2005-07-05 | 2010-07-27 | Cytoskeleton, Inc. | Detection of Rho proteins |
| PL2234635T3 (pl) * | 2007-12-19 | 2017-08-31 | Rhovac Aps | Immunoterapia oparta na białkach rhoc |
-
2008
- 2008-12-18 PL PL08862897T patent/PL2234635T3/pl unknown
- 2008-12-18 WO PCT/DK2008/050324 patent/WO2009076966A2/en not_active Ceased
- 2008-12-18 CA CA2710061A patent/CA2710061C/en active Active
- 2008-12-18 US US12/808,649 patent/US9163077B2/en active Active
- 2008-12-18 DK DK08862897.9T patent/DK2234635T3/en active
- 2008-12-18 JP JP2010538345A patent/JP2011506497A/ja active Pending
- 2008-12-18 ES ES08862897.9T patent/ES2623447T3/es active Active
- 2008-12-18 AU AU2008338063A patent/AU2008338063B2/en active Active
- 2008-12-18 EP EP08862897.9A patent/EP2234635B1/en active Active
-
2014
- 2014-02-17 JP JP2014027157A patent/JP5813801B2/ja active Active
-
2015
- 2015-09-16 JP JP2015182828A patent/JP6084671B2/ja active Active
- 2015-09-24 US US14/863,691 patent/US20160008448A1/en not_active Abandoned
-
2019
- 2019-04-19 US US16/389,676 patent/US20190247480A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6943545B2 (ja) | 腫瘍特異的なネオ抗原を同定する組成物および方法 | |
| RU2753246C2 (ru) | Составы вакцин против неоплазии и способы их получения | |
| CN105025932B (zh) | 癌疫苗及使用其的治疗方法 | |
| Bolhassani et al. | Enhanced immunogenicity of HPV16E7 accompanied by Gp96 as an adjuvant in two vaccination strategies | |
| US20160022791A1 (en) | Cytotoxic T Lymphocyte Inducing Immunogens For Prevention Treatment and Diagnosis of Cancer | |
| JP2007511547A5 (OSRAM) | ||
| US8263560B2 (en) | HPV 16 peptide vaccine for head and neck cancer | |
| CA2513104A1 (en) | Survivin-derived peptides and use thereof | |
| JP2006526628A (ja) | Ｈｌａ−ａ２腫瘍関連抗原ペプチドおよび組成物 | |
| JP2011506497A5 (OSRAM) | ||
| JP6406647B2 (ja) | 細胞性免疫誘導ワクチン | |
| CN101796070A (zh) | p53肽疫苗 | |
| CN101146550A (zh) | 用于预防或治疗目的的激发、增强和维持对i类mhc-限制性表位的免疫应答的方法 | |
| KR101810840B1 (ko) | 암의 예방 및 치료용 msi-특이적 프레임쉬프트 펩티드(fsp) | |
| CN112867502A (zh) | Herv-k衍生抗原作为共有肿瘤抗原用于抗癌疫苗 | |
| WO2017177907A1 (zh) | 抗免疫检查点pd-l1和pd-l2肿瘤疫苗 | |
| WO2017177908A1 (zh) | Pd-l1和pd-l2重组蛋白及其用途 | |
| Velders et al. | Identification of peptides for immunotherapy of cancer. It is still worth the effort | |
| WO2016011432A2 (en) | Identification of immunogenic mhc class ii peptides for immune-based therapy | |
| US10286050B2 (en) | Multi-epitope TARP peptide vaccine and uses thereof | |
| US11191828B2 (en) | MHC class I associated hepatitis B peptides | |
| JPWO2020260898A5 (OSRAM) | ||
| CN108250266A (zh) | 一种hla-a11限制性gpc3源性多肽及包含它的疫苗 | |
| De Leo | p53-based immunotherapy of cancer | |
| Ressing et al. | Vaccination Strategies to Induce T-Cell Immunity Against Tumours |